CT Angiogenesis Imaging with Mvivo Au Contrast Agent

TAVITIAN-CT-TUMOR

MediLumine’s Mvivo Au contrast agent was injected at a dose of 0.1 ml in nude mice grafted with Sdhb(-/-) and scanned with Mediso nanoScan PET/CT at Inserm U970, Paris, France (Viel T, Yoganathan T, Perez-Liva M, Tavitian B). 3D CT images of tumor vasculature were generated with Amira 3D visualization and analysis software for life sciences (Thermo Fisher Scientific).

Share This Post

More To Explore

Spring into Savings with MediLumine Products

For a limited time, we’re offering 20% off a curated selection of products designed to support in vivo imaging, preclinical IV access, and downstream sample

Managed by Carbon Digital